The current way to measure PDL-1 biomarkers will not stand the test of time
Yes
Date
08 Oct 2016Session
The current way to measure PDL-1 biomarkers will not stand the test of timePresenters
Naiyer RizviAuthors
N. RizviAuthor affiliations
- Na, Columbia Medical Center College of physicians & surgeons, 10032 - New York/US
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Second vote and conclusions
Presenter: Thomas Powles
Session: The current way to measure PDL-1 biomarkers will not stand the test of time
Resources:
Slides
Webcast
No
Presenter: Keith Kerr
Session: The current way to measure PDL-1 biomarkers will not stand the test of time
Resources:
Slides
Webcast
Introduction and first vote
Presenter: Thomas Powles
Session: The current way to measure PDL-1 biomarkers will not stand the test of time
Resources:
Slides
Webcast